Sunday, June 12, 2011

David Lacey to retire as Amgen SVP of discovery research, South SF site head

David Lacey, Amgen Inc.’s South San Francisco chief and senior vice president of discovery research for the company overall, will retire.
Lacey, 58, was not immediately available to talk about his plans, but is expected to take on new roles in the life sciences industry that allow him more time with his family. It was not clear when Lacey's retirement would take effect.
Employees have described Lacey, who joined Amgen (NASDAQ: AMGN) in 1994 from Washington University and spent 12 years at the company's Thousand Oaks headquarters, as a "cornerstone" of the company. He moved to the South San Francisco site in 2006.

No comments:

Post a Comment